Science & Tech · Gadgets & EVs · 9 hrs ago
Huawei unveils its first continuous glucose monitor
Huawei has unveiled the Sense G1, its first continuous glucose monitor.
The arm-worn device is designed to track glucose levels day and night and show readings on a phone or smartwatch.
A small sensor measures glucose through fluid under the skin, so users do not need to prick a finger for each reading.
It is intended for one person, needs no calibration and can be worn for up to 16 days.
China’s medical regulator approved it as a Class III device, the country’s highest risk category for medical devices.
Huawei has been developing health-monitoring technology, but its existing smartwatches cannot directly measure glucose.
The device’s price and sale date have not been announced, and Huawei may share more details at an event later this month.
Huawei has unveiled the G1, its first continuous glucose monitor.
The arm-worn sensor tracks glucose throughout the day and night and can alert users when readings fall outside normal ranges.
China’s National Medical Products Administration granted the device Class III approval.
Huawei says the sensor is intended for one user and can be worn for up to 16 days.
The company has not announced a price or sale date.
- Who
- Huawei unveiled the G1.
- What
- The company’s first continuous glucose monitor tracks glucose levels using an arm-worn sensor.
- When
- Huawei announced it on November 13, 2026.
- Where
- China’s National Medical Products Administration granted it Class III approval; the sources do not state where it was unveiled.
- Why
- It is designed to monitor glucose levels throughout the day and night.
This story does not have two clearly opposing sides.
Huawei Terminal BG CTO Li Xiaolong first wore a test version of the device.
Huawei introduced its TruSense health monitoring system.
Huawei announced the G1 after it received Class III approval in China.
- Device
- Huawei G1, the company’s first continuous glucose monitor
- Wear time
- Up to 16 days
- Approval
- Class III approval from China’s National Medical Products Administration
- Development
- Li Xiaolong first wore a test version in December 2023
- Price and sale date
- Not announced